^
    Back
    Association details:
    Biomarker:ALK positive
    Cancer:Peripheral T-cell Lymphoma
    Drug:Alunbrig (brigatinib) (EGFR inhibitor, ALK inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    12/21/2023
    Excerpt:
    Peripheral T-Cell Lymphomas: SUGGESTED TREATMENT REGIMENS ALCL…ALK inhibitors (for ALK-positive ALCL only)…Brigatinib…